Implications of GABAergic neurotransmission in Alzheimer's disease

Y Li, H Sun, Z Chen, H Xu, G Bu… - Frontiers in aging …, 2016 - frontiersin.org
Alzheimer's disease (AD) is characterized pathologically by the deposition of β-amyloid
peptides (Aβ) and the accumulation of neurofibrillary tangles (NFTs) composed of hyper …

Astrocytes: GABAceptive and GABAergic cells in the brain

J Liu, X Feng, Y Wang, X **a, JC Zheng - Frontiers in cellular …, 2022 - frontiersin.org
Astrocytes, the most numerous glial cells in the brain, play an important role in preserving
normal neural functions and mediating the pathogenesis of neurological disorders. Recent …

Astrocytic GABA transporter activity modulates excitatory neurotransmission

K Boddum, TP Jensen, V Magloire… - Nature …, 2016 - nature.com
Astrocytes are ideally placed to detect and respond to network activity. They express
ionotropic and metabotropic receptors, and can release gliotransmitters. Astrocytes also …

Circadian rhythms in the blood–brain barrier: impact on neurological disorders and stress responses

N Schurhoff, M Toborek - Molecular brain, 2023 - Springer
Circadian disruption has become more prevalent in society due to the increase in shift work,
sleep disruption, blue light exposure, and travel via different time zones. The circadian …

GABA as a rising gliotransmitter

BE Yoon, CJ Lee - Frontiers in neural circuits, 2014 - frontiersin.org
Gamma-amino butyric acid (GABA) is the major inhibitory neurotransmitter that is known to
be synthesized and released from GABAergic neurons in the brain. However, recent studies …

Circadian blueprint of metabolic pathways in the brain

CM Greco, P Sassone–Corsi - Nature Reviews Neuroscience, 2019 - nature.com
The circadian clock is an endogenous, time-tracking system that directs multiple metabolic
and physiological functions required for homeostasis. The master or central clock located …

Evaluation of bumetanide as a potential therapeutic agent for Alzheimer's disease

B Boyarko, S Podvin, B Greenberg… - Frontiers in …, 2023 - frontiersin.org
Therapeutics discovery and development for Alzheimer's disease (AD) has been an area of
intense research to alleviate memory loss and the underlying pathogenic processes. Recent …

Reduced tonic inhibition in striatal output neurons from Huntington mice due to loss of astrocytic GABA release through GAT-3

AM Wójtowicz, A Dvorzhak, M Semtner… - Frontiers in neural …, 2013 - frontiersin.org
The extracellular concentration of the two main neurotransmitters glutamate and GABA is
low but not negligible which enables a number of tonic actions. The effects of ambient GABA …

Novel insight into astrocyte-mediated gliotransmission modulates the synaptic plasticity in major depressive disorder

L Lei, YF Wang, CY Chen, YT Wang, Y Zhang - Life Sciences, 2024 - Elsevier
Major depressive disorder (MDD) is a form of glial cell-based synaptic dysfunction disease
in which glial cells interact closely with neuronal synapses and perform synaptic information …

Crosstalk between GABAA receptors in astrocytes and neurons triggered by general anesthetic drugs

DS Wang, L Ju, AG **uelo, K Kaneshwaran… - Translational …, 2024 - Elsevier
General anesthetic drugs cause cognitive deficits that persist after the drugs have been
eliminated. Astrocytes may contribute to such cognition-impairing effects through the release …